Thomas Teisseyre Sells 24,188 Shares of Hyperfine (NASDAQ:HYPR) Stock

Hyperfine, Inc. (NASDAQ:HYPR) COO Thomas Teisseyre sold 24,188 shares of the business’s stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total transaction of $29,267.48. Following the completion of the sale, the chief operating officer directly owned 354,648 shares in the company, valued at $429,124.08. This trade represents a 6.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Hyperfine Price Performance

Shares of NASDAQ:HYPR traded up $0.02 during mid-day trading on Wednesday, reaching $1.17. 352,549 shares of the company were exchanged, compared to its average volume of 502,890. The firm has a market cap of $113.69 million, a price-to-earnings ratio of -2.66 and a beta of 1.09. The firm’s 50-day simple moving average is $1.16 and its 200 day simple moving average is $1.20. Hyperfine, Inc. has a 1 year low of $0.53 and a 1 year high of $2.22.

Hyperfine (NASDAQ:HYPR) last announced its earnings results on Wednesday, March 18th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.02. Hyperfine had a negative return on equity of 95.09% and a negative net margin of 262.29%.The company had revenue of $5.29 million for the quarter, compared to analyst estimates of $5.30 million. On average, research analysts forecast that Hyperfine, Inc. will post -0.57 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Hyperfine

Institutional investors have recently modified their holdings of the business. EP Wealth Advisors LLC purchased a new stake in shares of Hyperfine during the fourth quarter worth $34,000. Sanctuary Advisors LLC boosted its holdings in Hyperfine by 130.9% in the fourth quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock valued at $39,000 after purchasing an additional 22,638 shares during the period. Kathmere Capital Management LLC purchased a new position in Hyperfine in the fourth quarter valued at $51,000. Millennium Management LLC acquired a new position in Hyperfine during the 4th quarter worth $55,000. Finally, Cerity Partners LLC acquired a new position in Hyperfine during the 4th quarter worth $59,000. Institutional investors and hedge funds own 15.03% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on HYPR shares. Zacks Research raised Hyperfine to a “hold” rating in a research note on Thursday, March 19th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Hyperfine in a research report on Thursday, January 22nd. Finally, Lake Street Capital boosted their price target on shares of Hyperfine from $2.00 to $2.50 and gave the stock a “buy” rating in a research note on Thursday, March 19th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $1.45.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.